Evaluating the prognosis of oral squamous cell carcinoma patients via L3 skeletal muscle index-Reference-Cited by-同舟云学术

Evaluating the prognosis of oral squamous cell carcinoma patients via L3 skeletal muscle index

Published:2021-11-24 Issue: Volume: Page:
ISSN:1354-523X
Container-title:Oral Diseases
language:en
Short-container-title:Oral Dis

Author:

Lu Xinyan¹^ORCID,Tian Ying²,Huang Jiaxin¹³,Li Fei¹,Shao Tingru¹,Huang Guangzhao¹,Lv Xiaozhi¹^ORCID

Affiliation:

1. Department of Oral & Maxillofacial Surgery Southern Medical University NanFang Hospital Guangzhou China

2. NanFang PET Center Southern Medical University NanFang Hospital Guangzhou China

3. Department of Oral Emergency and General Dentistry Affiliated Stomatology Hospital of Guangzhou Medical UniversityGuangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Dentistry,Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/odi.14074

Reference41 articles.

1. Imaging of sarcopenia: old evidence and new insights

2. The clinical value of nutritional care before and during active cancer treatment;Aprile G.;Nutrients,2021

3. High percentage of cancer outpatients are at nutritional risk

4. Nutritional Interventions in Head and Neck Cancer Patients Undergoing Chemoradiotherapy: A Narrative Review

5. X-Tile

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and Association of Sarcopenia with Mortality in Patients with Head and Neck Cancer: A Systematic Review and Meta-Analysis;Annals of Surgical Oncology;2024-06-07

2. Prognostic value of ¹⁸F‐FDG PET radiomics and sarcopenia in patients with oral squamous cell carcinoma;Medical Physics;2024-01-22

3. Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol;PLOS ONE;2023-11-27

4. Role of sarcopenia on survival and treatment-related toxicity in head and neck cancer: a narrative review of current evidence and future perspectives;European Archives of Oto-Rhino-Laryngology;2023-05-15

5. Evaluation of sarcopenia as a prognostic biomarker in locally advanced head and neck squamous cell carcinoma;Biomarkers in Medicine;2023-01